Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Change in Account Payables (2018 - 2025)

Historic Change in Account Payables for Organogenesis Holdings (ORGO) over the last 8 years, with Q3 2025 value amounting to -$994000.0.

  • Organogenesis Holdings' Change in Account Payables rose 7434.84% to -$994000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year increase of 27387.61%. This contributed to the annual value of -$2.4 million for FY2024, which is 209629.63% down from last year.
  • Per Organogenesis Holdings' latest filing, its Change in Account Payables stood at -$994000.0 for Q3 2025, which was up 7434.84% from $4.1 million recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Change in Account Payables peaked at $4.5 million during Q3 2021, and registered a low of -$4.4 million during Q1 2024.
  • Moreover, its 5-year median value for Change in Account Payables was -$994000.0 (2025), whereas its average is $277368.4.
  • As far as peak fluctuations go, Organogenesis Holdings' Change in Account Payables skyrocketed by 44254.0% in 2022, and later plummeted by 297539.68% in 2024.
  • Organogenesis Holdings' Change in Account Payables (Quarter) stood at -$1.4 million in 2021, then plummeted by 43.96% to -$2.0 million in 2022, then skyrocketed by 277.56% to $3.6 million in 2023, then increased by 2.73% to $3.6 million in 2024, then tumbled by 127.23% to -$994000.0 in 2025.
  • Its Change in Account Payables was -$994000.0 in Q3 2025, compared to $4.1 million in Q2 2025 and -$2.5 million in Q1 2025.